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A B S T R A C T
Introduction. Sexual function is an important aspect of quality of life, and may be impaired after (pelvic) radiation.
Aim. The aim of this study was to identify practice, responsibility attitudes, knowledge, and barriers of Dutch
radiation oncologists regarding sexual counseling.
Methods. A cross-sectional survey was performed using a 28-item questionnaire sent to all members of the Dutch
Society for Radiotherapy and Oncology.
Main Outcome Measures. Self-reported practice, knowledge, barriers, need for training and responsibility attitudes
in regard to demographic characteristics.
Results. Of the surveyed sample, 54.6% of the radiation oncologists completed the instrument (n = 119). Frequency
of discussing sexual function was fluctuating, depending on the type of tumor. The majority of the responding
radiation oncologists (75%) agreed that discussing sexual function is their responsibility, about one-third (33.6%)
pointed at the involved specialist (surgeon, urologist, gynecologist, or oncologist), a fifth also considered the general
practitioner responsible (21%). Additional training about discussing sexuality was required according to 44.4%, the
majority agreed that sexual counseling should be a regular component of radiation oncology residency (n = 110,
94%). Barriers most mentioned included patient is too ill (36.2%), no angle or reason for asking (32.4%), advanced
age of the patient (27%) and culture/religion (26.1%). For prostate cancer patients, phosphodiesterase 5 inhibitor
information was supplied regularly (49.2%) and often (40.7%).
Conclusions. Radiation oncologists generally perform sexual counseling in case of pelvic radiation therapy, but not
consistently in case of gastrointestinal, breast, and other cancers. The majority of radiation oncologists considered
counseling on sexual functioning as a part of their job, some also pointed at the referring specialist or general
practitioner. The findings suggest that awareness about sexual dysfunction is present among radiation oncologists,
but responsibility for active counseling is uncertain. Results emphasize the need for providing educational and
practical training, as well as a list for specialized referral. Krouwel EM, Nicolai MP, van der Wielen GJ, Putter
H, Krol ADG, Pelger RCM, Incrocci L, and Elzevier HW. Sexual concerns after (pelvic) radiotherapy: is
there any role for the radiation oncologist? J Sex Med 2015;12:1927–1939.
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Introduction
C ancer is a life-threatening disease, but becauseof expanding treatment options, it is turning
into a condition with decreasing mortality. As
patients live longer after diagnosis, attention for
late effects of treatment and quality of life are of
increasing importance, both during treatment and
throughout survivorship [1]. A typical problem is
that physicians and patients tend to concentrate on
intensive medical treatment options and underesti-
mate the late treatment-related adverse effects
[2,3].
Radiotherapy (RT) is commonly used to treat
cancer, whether as external-beam RT or brachy-
therapy. Specifically, pelvic RT for the treatment of
uterine, cervical, bladder, prostatic, rectal, or anal
cancer is known for its influence on sexual function,
affecting both men and women [4,5]. Sexual dys-
function (SD) caused by pelvic RT originates from
injury to organs, vessels, persistent inflammatory
responses, hormonal deprivation, and psychologic
responses, although the molecular etiology is not
completely understood [6–13]. Tissue toxicity is
depending on the accumulated radiation dose to
the pelvic area [14–16]. Possible late effects of
pelvic RT include pelvic fibrosis, resulting in endo-
thelial damage, inflammation, ischemia, and even-
tually necrosis [17]. Vaginal discharge, skin
erythema, and fatigue result in low scores of satis-
faction with sexual function in women after pelvic
RT [18–20]. Three years after RT for prostate
cancer, 38% of pre-treatment potent men reported
erectile dysfunction (ED), resulting in decreased
satisfaction with sexual function [21]. Preoperative
RT in primary rectal cancer has negative effects on
sexual function in men and women [5]. RT on other
areas of the body also has the ability to affect sexual
function by inducing fatigue, psychosocial and
emotional problems, sensory loss and reduced fer-
tility [22], also breast radiation can have an impact
on long-term cosmetic outcomes [23].
Despite the significant effect on sexual function,
clinical assessment of treatment-induced SD follow-
ing RT is an underexposed item during regular radia-
tion oncologist consultations [24–26]. For this
reason, patients should be actively informed on prob-
lems associated with radiation-induced SD and must
be guided toward appropriate therapeutic options.
To our knowledge, information concerning the atti-
tude of radiation oncologists is barely available yet.
So far, research focusing on radiation oncologists’
attitudes regarding the provision of sexual counseling
only involved a Chinese study [25]. However, the
Global Survey of Sexual Attitudes and Behaviors
revealed that women in East Asia were the least likely
to talk to a doctor about their sexual issues (9% vs.
18–40% in non-Asian countries) [27]. For this
reason, the Chinese survey might differ significantly
from a non-Asian perspective.
As medical doctors are the major information
source of treatment-induced morbidity and have a
legal obligation to inform their patients on
treatment-induced morbidity, investigating their
current sexual counseling practices is of significant
importance. By collecting data and demonstrating
possible omissions, the development of a consis-
tent and effective sexual health care counseling
policy for patients receiving RT can be established.
Aims
The aim of this study was to investigate the atti-
tude, knowledge, and barriers of Dutch radiation
oncologists toward informing their patients on
the possibility of treatment-induced SD. We also
investigated the need for training and perceptions
concerning responsibility for addressing sexual
issues, in order to clarify whether or not this is
felt to be the radiation oncologist’s responsibility.
The data obtained could be used to adapt and
develop educational training, guidelines and stan-
dard operating procedures regarding the counsel-




A cross-sectional postal survey was held among
radiation oncologists and RT residents holding
active practice in The Netherlands.
Cohort Identification and Survey Process
Questionnaires were sent to all radiation oncolo-
gists and RT residents (n = 234) who were member
of the Dutch Association for Radiotherapy and
Oncology (NVRO) at the time of Spring 2012. An
information letter concerning the study and a
postpaid return envelope were added, as well as an
opt-out possibility. To facilitate the response rate,
the initial mailing was followed by two reminders
in August and November 2012. All data were col-
lected anonymously in order to prevent a self-
reporting bias.
Instrument Design and Development
Identified participants were sent a 28-item ques-
tionnaire developed by the authors, content based
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on questionnaires successfully used for similar
studies among cardiologists, urologists, surgical
oncologists and oncology nurses in the Nether-
lands (Appendix 1) [28–31]. A pilot study with 24
radiation oncologists was performed to evaluate the
questions and adjust the questionnaire for the final
survey according to the comments. As a result of the
pilot study, questions on practice attitudes were
separated for tumor-specific areas of specialization,
and participants were given the opportunity to
answer for two different areas of specialization.
Data Analysis
Quantitative data were analyzed using SPSS 20
(SPSS Inc., Chicago, IL, USA). The results were
described using frequency distribution and descrip-
tive statistics. Missing data (i.e., not completed
questions) were not added with percentage calcu-
lations; n is always mentioned to clarify. Bivariate
associations between demographic information
and specific answers were made with Pearson’s
chi-squared test and Cochran-Armitage trend test.
Ethical Considerations
In The Netherlands, research that does not
involve patients or interventions is not subject to
approval from ethical boards. In previous research
where nurses were the participants, the Medical
Ethics Committee was consulted in order to verify
whether ethical approval was necessary. As the
study did not concern any information recorded
by the investigator in such a manner that subjects
could be identified, directly or through identifiers
linked to the subjects, and as it did not compro-
mise the study participants’ integrity, the Com-
mittee declared that no formal ethical approval
was needed [32]. Participation was fully volun-
tarily and anonymous, an opt-out possibility was
implemented.
Main Outcome Measures
• Demographic questions relating function, expe-
rience, gender, age, and focus areas.
• Self-reported practice patterns regarding sexual
counseling and providing information on
sexuality.
• Opinion about responsibility for sexual counsel-
ing and referral behavior.
• Barriers toward assessing sexual health issues.
• Knowledge on sexual problems in reference to
RT.
• Need for additional training.
Results
Participants
Questionnaires were sent to 234 members of the
NVRO. The final response rate was 54.6%, for
further details on participation see Figure 1.
Demographics of Respondents
Overall, there was an almost equivalent amount of
men and women with a median age of 47 years.
There was variation in experience, 52.9% of all
respondents had over 15 years of experience in RT.
All demographic information is displayed in
Table 1.
Practice Patterns
Data about practice attitudes regarding sexual
function were separated according to area of spe-
cialization. Each radiation oncologist was able to
provide answers for two areas of specialization and
answer the questions for each type of patient. The
results to the question “How often do you discuss
sexual functioning of the patient?” are featured in
Figure 2.
According to the radiation oncologists involved
with care for urology patients (n = 59), information
about the risk for ED after prostatic RT is given
regularly (16.9%) and often (81.3%). The majority
declared to inform patients about the use of phos-
phodiesterase 5-inhibitors regularly (49.2%) and
often (40.7%). A few radiation oncologists stated to
rarely or never inform patients about erection
medication (10.2%). Participants involved with
gynecology patients (n = 27) gave information
about sexual function after RT for cervical cancer
rarely (n = 4, 14.8%) and regularly plus often
(n = 23, 85.2%). Physicians involved with breast
cancer patients (n = 48) provided information about
sexuality in respect to breast radiation never
(12.5%), rarely (50%), regularly (18.8%), and often
(18.8%).
During conversations about sexual function, the
partner was present in half of the cases (n = 32,
28.8%), more than half of the cases (n = 37,
33.3%) or almost always (n = 38, 34.2%). As for
the question “How long does it take before treat-
ment adverse effects to sexual function start to
decrease?” 62.7% of the respondents (n = 69)
stated from experience that adverse effects from
RT on sexual function remain forever. Forty-one
responders estimated that sexual adverse effects
remain for about 3–24 months (37.3%). The
majority believed that women who underwent RT
for cervical cancer often (82.5%, n = 94), regularly
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(14%, n = 16) and sometimes (3.5%, n = 4) expe-
rience sexual problems, after RT for breast cancer
it was believed that women experience problems
often (7%, n = 8), regularly (38.3%, n = 44), some-
times (36.5%, n = 42) and never/rarely (18.3%, n =
21).
Responsibility and Referring
Evaluation of treatment-induced SD is the respon-
sibility of the radiation oncologist according to
the majority of the respondents (n = 87, 75%).
Remaining respondents considered neutral
(n = 22, 19%) or disagreed having responsibility
(n = 7, 6%). In the following question regarding
responsibility of other health care providers (with a
multiple answer possibility), a third of the respon-
dents pointed at the referring specialist (e.g., the
surgeon, urologist, gynecologist or oncologist)
regarding responsibility for discussing SD (n = 40,
33.6%). A fifth considered the general practitioner
responsible (n = 25, 21%). The primary responsi-
bility of sexual counseling was separately analyzed
among all pelvic radiation oncologists (n = 65,
54.6%), consisting of all radiation oncologists with
urology and gynecology as their primary special-
ism. In this pelvic radiation group, the referring
specialist (n = 19, 29.2%) and general practitioner
(n = 9, 13.8%) were also felt to be responsible for
Figure 1 Flow chart of the final participants.
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addressing sexual functioning. Sixteen percent of
respondents stated that the patient has its own
responsibility to initiate discussion on SD.
To the question regarding patient referral in
case of SD, 75.9% (n = 88) confirmed to have the
possibility of referring their patients to an expert
on this topic, 24.1% of the radiation oncologists
(n = 28) was not familiar where to refer patients.
The majority of the respondents indicated to be in
need of a list with qualified sexual health care pro-
viders for referral (n = 84, 72.4%).
Barriers
The respondents were given a list of possible bar-
riers for discussing SF, in order for them to indicate
to which extent they agreed (Table 2). Radiation
oncologists mentioned “patient is too ill” to discuss
sexual issues as a major barrier (36.2%). The second
barrier, to which 32.4% agreed, was “no angle or
reason for asking.” Other barriers were “advanced
age of the patient” (27%), “culture/religion”
(26.1%), “language/ethnicity” (24.5%), “sexuality
is not a patient’s concern” (23.9%), “patient doesn’t
bring up the subject” (20%), “lack of training”
(19.3%), and “patient is not ready to discuss sexual
functioning” (13.1%). The barriers that did not
keep radiation oncologists from sexual counseling
were all barriers regarding gender, “it’s someone
else’s task” (2.6%), “age difference between you
and the patient” (3.5%), “afraid to offend the
patient”(3.5%), and embarrassment (5.3%). The
results to the question concerning the provision of
information about treatment-related SD in regard
to the age of a patient are displayed in Figure 3.
Knowledge and Training
To the question regarding knowledge, the majority
of radiation oncologists stated to possess some
knowledge concerning SD (n = 87, 67.2%), a
quarter of all respondents stated to have sufficient
knowledge on SD (n = 29, 25%) and the remain-
ing respondents stated to have not much knowl-
edge on SD (n = 9, 7.8%). Radiation oncologists
under the age of 47, possessed less knowledge of
SD in comparison to respondents of 47 years and
older (P = 0.046). Gender did not influence the
knowledge of SD (P = 0.513).
Of all responding radiation oncologists, 44.4%
indicated to be in need of additional training
regarding discussing sexuality with their patients
(n = 50). Female respondents more often wished
additional training than their male colleagues
Table 1 Demographic characteristics of the respondents
(n = 119)
n (%)
Age (years) 119 (100)
Median 47 (range 26–66)















University hospital 60 (50.4)
District general teaching hospital 27 (22.7)
District general hospital 22 (18.5)
Categorical cancer hospital 4 (3.4)
University and district general hospital 3 (2.6)
Independent consultant 1 (0.8)
Not available 2 (1.7)
SD = standard deviation.
Table 2 Barriers to sexual counseling; sorted from most






n (%) n (%) n (%)
Patient is too ill 41 (36.2) 36 (31.9) 36 (31.9)
No angle or reason for asking 37 (32.4) 21 (18.4) 56 (49.2)
Advanced age of the patient 31 (27.0) 38 (33.0) 46 (40.0)
Culture/religion 30 (26.1) 32 (27.8) 53 (46.1)
Language/ethnicity 28 (24.5) 33 (29.0) 53 (46.5)
Sexuality is not a patient’s
concern
27 (23.9) 32 (28.3) 54 (47.8)
Patient does not bring up
the subject
23 (20.0) 19 (16.5) 73 (63.5)
Lack of training 22 (19.3) 35 (30.7) 57 (50.0)
Patient is not ready to
discuss sexual functioning
15 (13.1) 39 (33.9) 61 (53.0)
Presence of a third party 13 (11.3) 36 (31.3) 66 (57.4)
Lack of time 13 (11.3) 21 (18.3) 81 (70.4)
Sexuality is a private matter 12 (10.5) 15 (13.2) 87 (76.3)
Lack of knowledge 10 (8.8) 31 (27.2) 73 (64.0)
I feel uncomfortable 9 (7.9) 15 (13.2) 90 (78.9)
Embarrassment 6 (5.3) 14 (12.3) 94 (82.4)
Afraid to offend the patient 4 (3.5) 15 (13) 96 (83.3)
Age difference between you
and patient
4 (3.5) 6 (5.2) 105 (91.3)
It’s someone else’s task 3 (2.6) 24 (20.9) 88 (76.5)
Patient is the opposite gender 2 (1.7) 5 (4.3) 108 (93.9)
Patient is the same gender – 3 (2.6) 112 (97.4)
For ease of presentation, results in response categories “Strongly agree” and
“agree” have been merged, as have “strongly disagree” and “disagree.”
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(55% vs. 33.9%, P = 0.023). Age (<47 vs. ≥ 47
years) did not influence the wish for training
(48.3% vs. 41.1%, P = 0.432). Almost all respon-
dents agreed that sexual counseling should be a
regular component of the radiation oncology resi-
dency (n = 110, 94%).
Discussion
Key findings of this study are that radiation
oncologists routinely discuss sexuality with their
urology and gynecology patients, but not so con-
sistently with their gastrointestinal-, breast-, and
other cancer patients. The majority of radiation
oncologists considered counseling on sexual func-
tioning as part of their job, a third also pointed at
the referring specialist as well as a fifth indicated
that to be a responsibility of the general practitio-
ner. More than half of the radiation oncologists
indicated that radiation effects on sexual function
usually persist forever. The majority of radiation
oncologists stated to have some knowledge on
treatment-related SD. Young radiation oncologists
had less knowledge of the topic; illustrating
experience might play a role in counseling. An




















































































































































































































































Figure 2 Results to the question “How often do you discuss sexual functioning of the patient?,” allocated for type of cancer.
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indicated that they would benefit from additional
training regarding sexual counseling in radiation
practice; female physicians indicated this wish
more often than male physicians. Almost all
respondents agreed that training in sexual coun-
seling should be a regular part of RT residency.
Barriers for sexual counseling included patient is
too ill, no angle or reason for asking, advanced age,
and culture or religion.
Comparison with Literature
To our knowledge, this survey was the first evalua-
tion in Europe of radiation oncologists’ attitudes
and practice patterns regarding sexual health. In
China, a similar evaluation was performed among
radiation oncologists, also evaluating attitudes and
behavior toward sexual issues of patients who
received RT [25]. In line with our results, the radia-
tion oncologists felt responsible for addressing the
issue, nonetheless, dissimilar to our results they
hardly addressed the issue spontaneously but only
when the patient explicitly consulted them on this
issue. The majority of Chinese radiation oncolo-
gists expressed the need for training to enable them
to provide guidance to patients, in the present study
this was less than fifty percent. Wang et al. [25]
found 41.7% of their surveyed radiation oncolo-
gists to be uncomfortable discussing sexual func-
tioning with a patient, compared with 20% of the
Dutch radiation oncologists, illustrating that the
East Asian attitude regarding sexuality might differ
from the non-Asian perspective.
In the United Kingdom, a survey among special-
ist gynecologic oncology nurses and an evaluation
of the content of patient brochures showed a
prominent lack of psychosexual content for
example regarding vaginal dilatation in both clini-
cal counseling and written materials [33]. Vaginal
dilatation after pelvic radiation is recommended in
order to maintain patency of the vagina. Although
there is no reliable evidence on preventing stenosis,
several reports suggest that women who dilate their
vagina after RT reported and measured less stenosis
[34]. Furthermore, a psycho-educational interven-
tion is demonstrated to increase compliance of the
use of vaginal dilatators compared with supplying
information only [35]. As for Faithfull et al. their
“information after pelvic radiation” survey, physi-
cians rarely provided patient education in relation
to sexual health advice and vaginal dilatation [33].
Patient education was considered a nursing or
radiographer role; however, the physician was
thought to be the one to evaluate on a patient’s
compliance regarding any intervention. Notewor-
thy, it appeared information was solely provided for
gynecology patients, even though pelvic radiation
therapy is also frequently used for the treatment of
women with bladder, rectal and anal tumors.
The discrepancy between doctors’ assumptions
and the actual experienced complaints after receiv-
ing pelvic RT have also been emphasized in other
reports, showing underreport of vaginal discomfort
and underestimation of ED by physicians. In the
United Kingdom, RT follow-up consultations were
observed in order to determine the clinical assess-
ment of treatment-induced female sexual difficul-
ties [26]. Results showed acknowledgment by both
patient and physician in the challenge of discussing
sexual concerns. Barriers included the different pri-
orities during consultations; like attention for pos-
sible recurrence of disease, lack of time, lack of









































































Figure 3 How often do you discuss
sexual concerns with patients in the
following age categories?
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Vistad et al. compared physician-assessed mor-
bidity (including vaginal discomfort) with reported
symptoms from patients treated with RT for cer-
vical cancer. Patient morbidity scores correlated
poorly with data reported by physicians, confirm-
ing underreporting and underestimation of
intestinal and bladder morbidity [24]. Vaginal dis-
comfort was not compared with physician data; at
follow-up only two-thirds of the patients were
examined for vaginal symptoms, indicating the
physician did not actively counsel at all.
Showalter et al. surveyed the estimation of 926
radiation oncologists on how often RT affected
recovery of ED after radical prostatectomy. Signifi-
cantly less radiation oncologists (47%) predicted a
“major/total detrimental effect” to erectile function
following RT in comparison with urologists (69%)
[36]. With respect to patient-reported outcomes
regarding RT for prostate cancer, the number of
patients reporting inability to achieve an erection
sufficient for intercourse after 2 (60.8%), 5
(71.9%), and 15 years (93.9%) illustrates the under-
estimation of the radiation oncologists [37].
Clearly, the main barriers toward sexual coun-
seling detected in the current survey can be
opposed. The primary reason for not discussing
sexual health “the patient is too ill” should be
questioned, considering the body of evidence
reporting on the importance of sexual function to
the quality of life of patients with all sorts of cancer
patients being in early as well as advanced stages.
The second barrier, “no angle or reason for
asking,” can easily be tackled by the provision of
practical training on how to address the subject. By
providing informed consent and mentioning pos-
sible treatment-related SD, as well as additionally
notifying that the patient should address any con-
cerns, the key component of sexual health care has
already been performed. The third barrier,
advanced age of the patient, was also found in a
recent survey among a group of surgical oncolo-
gists [31]. Apparently, physicians seem to con-
sider that elderly patients are not sexually active
anymore and the subject is consequently not
relevant to discuss. This assumption might be
rather incorrect; according to a study on the preva-
lence of sexual activity among 3005 adults of
57–85 years, a serious percentage of older adults
is still sexually active [38], making this barrier
defeasible.
Limitations
This study has a few limitations. We used a
nonvalidated questionnaire, as there are no vali-
dated questionnaires available that assess the pro-
vision of sexual counseling by radiation oncologists.
In order to explore the aim of the study, specific
questions were required regarding sexual function
in the face of radiation therapy. For this reason, we
developed a particular questionnaire investigating
the aims and influencing factors instead of using a
validated, more general instrument. Nevertheless,
the questionnaire was based on other surveys of the
research group, which successfully assessed the
provision of sexual counseling by several (oncol-
ogy) health care providers [28–32]. As for an
approximation toward validation, an extensive pilot
study was performed and the instrument was
adjusted because of the comments. Test–retest
reproducibility of the questionnaire was not tested
due to the anonymous design; therefore, nothing
can be said about the reproducibility of the ques-
tionnaire. Another important limitation, which
may have resulted in over- or underestimation, is
that physician responses were self-reported.
Attempts were made to reduce this bias by collect-
ing the survey results anonymized.
The subdivisions by area of specialization
resulted in small numbers of radiation oncologists
in each group. For this reason, it was not possible
to reflect on the relationship between frequency of
counseling sexual function and demographic char-
acteristics of the respondents. At the same time,
because of the subdivisions we were able to
produce a detailed insight in patient groups who
might lack attention for SD following RT. Only
three residents responded to the survey, which
made it impossible to calculate differences in
results between residents and radiation oncolo-
gists. Different treatment settings, knowing
curative therapy, salvage therapy and palliative
radiation, where not in particular assessed in this
survey. As a result, nothing can be concluded about
the approach of radiation oncologists toward
patients receiving a different type of treatment.
The response rate was comparable with that of
other postal questionnaires among physicians [39].
Nevertheless, nonrespondents may have different
beliefs, attitudes and practice patterns than
respondents, this may have caused a nonresponse
bias and hence radiation oncologists may perform
less or more active counseling for sexual problems
after RT in daily practice.
Conclusions
Findings suggest that awareness of treatment-
induced SD is present among radiation
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oncologists, but responsibility for active counsel-
ing was not fully agreed on. Counseling on sexual
function is routinely done in case of pelvic radia-
tion therapy, but not consistent in case of gastro-
intestinal, breast and other cancers. According to
the majority of the radiation oncologists,
treatment-induced effects on sexual function are
lasting forever. Radiation oncologists stated the
preference for more detailed education about dis-
cussing SD in daily practice, and indicated that
education about sexual issues should be a routine
component of the residency in radiation oncology.
A list for specialized referral regarding patients
experiencing treatment-induced SD is requested.
Implications for Clinical Practice
In order to provide this component of care, radia-
tion oncologists need to have good communica-
tion skills, an open and nonjudgmental approach,
and knowledge of the potential consequences of
radiation therapy on sexuality. Especially for gas-
trointestinal patients who possibly receive radia-
tion on or close to the pelvic area, awareness
should be improved among radiation oncolo-
gists. Both standard education within radiation
oncology residency as additional education for
practicing radiation oncologists are strongly rec-
ommended. Radiation oncologists who have the
intention to integrate sexual health in their prac-
tice and would like to make use of a structured
framework, could for example counsel with the
widely used Permission (P), limited information
(LI), specific suggestions (SS), and intensive
therapy (IT) (PLISSIT) model [40]. Guidelines
and standard operating procedures for radiation
treatment should implement possible sexual side
effects and the importance of addressing them as a
part of informed consent and follow-up. Within
the oncology team, clear appointments should be
made regarding responsibility for addressing
sexual issues with every patient before and during
treatment. A list with specialized sexual health care
providers should become available for referral of
patients in need of specialized advice.
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Appendix 1. Questionnaire radiation oncologists (translated from Dutch).
This questionnaire concerns patients with any kind of cancer in any stage of 16 years and above.
Demographics
1. What is your age? .. . .. . ... years
2. What is your gender? M/F
3. What is your function?
□ Radiation oncologist
□ Resident
4. Where do you work?
□ Academic hospital
□ District general teaching hospital
□ District general hospital
5. What is/are your area(s) of specialization?
. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . ..
6. How long do you practice as a radiation oncologist?
□ 0–11 months □ 6–10 year
□ 1–2 year □ 11–15 year
□ 3–5 year □ 15 year or more
Sexual function
1. How often do you discuss the sexual function of the patient?
Specialty: . . .. . .. . . Specialty: . . .. . .. . .. . .
□ Never □ Never
□ Rarely □ Rarely
□ Sometimes □ Sometimes
□ Regularly □ Regularly
□ Often □ Often
2. In your current workplace, which percentage of the patients do you estimate to experience changed sexual function due to
radiotherapy?
Specialty: . . .. . .. . .—. . .. . .. . .. . ..% Specialty: . . .. . .. . .—. . .. . .. . .. . ..%
3. In the past year, with which percentage of your patients did you discuss their sexual function?
Specialty: . . .. . .. . .—. . .. . .. . .. . ..% Specialty: . . .. . .. . .—. . .. . .. . .. . ..%
4. In the past year, which percentage of your patients did you refer to another physician or health care provider for guidance of sexual
concerns or for answering questions regarding sexuality?
Specialty: . . .. . .. . .—. . .. . .. . .. . ..% Specialty: . . .. . .. . .—. . .. . .. . .. . ..%
5. The radiation oncologists carry responsibility for discussing sexual function with patients.
□ Totally agree □ Disagree
□ Agree □ Totally disagree
□ I don’t know
6. Otherwise, who has the responsibility for discussing sexual function? (multiple answers possible)







□ The patient has to raise the subject by itself.
□ Other: . . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . ...
7. During the informing of patients about the possible consequences of the radiotherapy (informed consent), do you also inform about
the possible consequences on sexual functioning?
Specialty: . . .. . .. . . Specialty: . . .. . .. . .. . .
□ Never □ Never
□ Rarely □ Rarely
□ Sometimes □ Sometimes
□ Regularly □ Regularly
□ Often □ Often
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8. During the follow-up appointments after treatment, do you get back to the subject sexual functioning?
Specialty: . . .. . .. . . Specialty: . . .. . .. . .. . .
□ Never □ Never
□ Rarely □ Rarely
□ Sometimes □ Sometimes
□ Regularly □ Regularly
□ Often □ Often
9. How often present patients sexual functioning complaints spontaneously?
Specialty: . . .. . .. . . Specialty: . . .. . .. . .. . .
□ Never □ Never
□ Rarely □ Rarely
□ Sometimes □ Sometimes
□ Regularly □ Regularly
□ Often □ Often
10. To which extent, do you possess sufficient knowledge to be able to discuss the subject sexual function with your patients?
□ No knowledge at all □ Sufficient knowledge
□ Not so much knowledge □ A lot of knowledge
□ Some knowledge
11. In your current workplace, how often did you inform men with prostate cancer about sexuality:
Never Rarely Regularly Often
A. The risk of erectile dysfunction □ □ □ □
B. The use of phosphodiesterase 5-inhibitors □ □ □ □
12. In your current workplace, how often did you inform about sexuality to:
Never Rarely Regularly Often
A. Male patients after radiotherapy on the prostate or rectum □ □ □ □
B. Female patients after radiotherapy on the breast or cervix □ □ □ □
















□ More than 2 years
□ The side-effects will remain forever
16. In your current workplace, how often did you supply information to patient after they received pelvic radiation, from the following
age categories?
Never Rarely Regularly Often
— 20–35 year □ □ □ □
— 36–50 year □ □ □ □
— 51–65 year □ □ □ □
— 66–75 year □ □ □ □
— 76 year and older □ □ □ □
17. If you discuss sexual function, how often is the partner present during these conversations?
□ Never / almost never
□ In less than half of the cases
□ In half of the cases
□ In more than half of the cases
□ Almost always / always
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18. In the subsequent table are reasons that possibly keep you from discussing sexual function with your patients. To which extent do you







Lack of time □ □ □ □ □
Lack of knowledge □ □ □ □ □
Lack of training □ □ □ □ □
It’s someone else’s task □ □ □ □ □
Patient is not ready to discuss SF □ □ □ □ □
Sexuality is not a patient’s concern □ □ □ □ □
Patient is too ill □ □ □ □ □
Concerned about making patient uncomfortable □ □ □ □ □
Reasons related to culture/religion □ □ □ □ □
Reasons related to language/ethnicity □ □ □ □ □







Patient is the opposite gender □ □ □ □ □
Patient is the same gender □ □ □ □ □
Presence of a third party □ □ □ □ □
Embarrassment □ □ □ □ □
Advanced age of the patient □ □ □ □ □
Sexuality is a private matter □ □ □ □ □
No angle or reason for asking □ □ □ □ □
I feel uncomfortable □ □ □ □ □
Patient doesn’t bring up the subject □ □ □ □ □
Afraid to offend the patient □ □ □ □ □




If yes, to . . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .. . .
20. Do you feel the need to extent your knowledge on discussing sexual function with your patients?
□ Yes
□ No
21. Do you believe counseling of sexual functioning should be a regular component of the radiation oncology residency?
□ Yes
□ No
22. Are you in need of a topical list with qualified sexual health care providers for referral of your patients?
□ Yes
□ No




Thank you very much for participating!
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